Replies to post #797498 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

We’ve had some “longs” of late claim unprecedented buys. I think you can look at that one of two ways:

1. They are lying about large buys for manipulation purposes.

Or

2. They are truthful and trying to keep their purchases public and, therefore, presumably unquestionably legitimate, with their reasoning more likely than not being that NWBO’s Advent acquisition, MHRA 3 RFI timeline guidelines, etc, give valid reasons to acquire massive shares leading up to a pivot point.

[DrHigh]

this post is on topic as it questions NWBO's potential expenditures



if his services are under contract with NWBO - how much are we paying him to post?? remember when he was dead broke and needed to sell his position and stop posting about NWBO but then was miraculously saved and doubled down on his social media defender tour? and now he added $700k in a month alone. This is possibly why we are having to dilute so many share. these guys are expensive??

[Doc logic]

FeMike,

According to evidence presented by DanishDude, yes, yes he did… buy all those shares. As mom used to ask me.. do you have something to say?; ). Best wishes.

[dstock07734]

You see what Yorkville has been doing after the deal with $NWBO? Yorkville knows what the real revolution is and has been collecting things either complementary to or synergistic with DCVax.

The longs will embrace a enormous future far beyond your wildest dream. Completely derisked investment!

A piece of advice: Don't bet against the revolution.

11-3-2025
CytoDyn Secures $30 Million Commitment from Yorkville Advisors
https://cytodyn.com/newsroom/detail/649/cytodyn-secures-30-million-commitment-from-yorkville

10-27-2025
Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing
http://pressviewer.com/profiles/investor/NewsPrint.asp?v=6&b=3018&ID=158802&m=rl&g=3007

7-31-2025
MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million
https://investors.medicinova.com/news-releases/news-release-details/medicinova-announces-signing-standby-equity-purchase-agreement

https://medicinova.com
https://medicinova.com/clinical-development/core/mn-001-nash/
Note MN-001 can inhibit PDE3 and PDE4.

7-30-2025
Rein Therapeutics Enters into Agreements for up to $21 Million in Flexible Financing
https://ir.reintx.com/news-releases/news-release-details/rein-therapeutics-enters-agreements-21-million-flexible

https://reintx.com/science/

7-8-2025
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
https://investors.predictive-oncology.com/news-releases/news-release-details/predictive-oncology-announces-10m-share-purchase-agreement

6-16-2025
Aptevo Therapeutics Inc. (the “Company”) entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”) with YA II PN, LTD
https://cbonds.com/news/3453219/

https://aptevotherapeutics.com/our-technology/#adaptir

https://sec.gov/Archives/edgar/data/1671584/000095017025087368/apvo-20250616.htm

2-12-2025
Indaptus Therapeutics Enters Standby Equity Purchase Deal With YA II PN
https://itiger.com/news/2511406300

https://indaptusrx.com/investors/wp-content/uploads/2025/05/INDP-May-2025.pdf

https://sec.gov/ix?doc=/Archives/edgar/data/0001857044/000149315225006052/form8-k.htm

2-11-2025
https://medicuspharma.com/medicus-pharma-ltd-enters-into-standby-equity-purchase-agreement-and-announces-intention-to-voluntarily-delist-from-the-tsx-venture-exchange-tsxv/
Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”) today announced that it has entered into a Standby Equity Purchase Agreement (the “SEPA“) with YA II PN, LTD (the “Investor“), an investment fund managed by Yorkville Advisors Global, LP. Pursuant to the SEPA, the Company has the option, at its sole discretion, to sell up to US$15,000,000 of the Company’s common shares (the “Shares“) to the Investor at any time during the 36-months following the date of the SEPA.

https://medicuspharma.com/portfolio-companies/
https://skinjectpatch.com

12-23-2024
FibroBiologics Announces $25 Million Financing
https://ir.fibrobiologics.com/news-events/press-releases/detail/55/fibrobiologics-announces-25-million-financing

12-19-2024
Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing
https://nwbio.com/announcement-5-million-convertible-note-financing/